Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leiomyosarcoma × pegfilgrastim × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Lymphoma 14 Neutropenia 9 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Neoplasms 6 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Triple Negative Breast Neoplasms 4 Hodgkin Disease 4 Chemotherapy-induced Neutropenia 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Colorectal Neoplasms 3 Breast Neoplasms, Male 3 Waldenstrom Macroglobulinemia 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, T-Cell, Peripheral 2 Lung Neoplasms 2

Interventions

Doxorubicin 6 pazopanib 4 Trabectedin 3 Sorafenib 3 Gemcitabine 3 Docetaxel 3 Dacarbazine 3 pembrolizumab 2 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 Nivolumab 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 tremelimumab 1 temsirolimus 1 saracatinib 1 rucaparib 1 romidepsin 1 olaratumab 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 durvalumab 1 cixutumumab 1 berzosertib 1 avelumab 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡